Aim. Neuropathic pain affects 7–10% of the population, with most of the patients receiving
inadequate and incomplete treatment. Owing to the high financial burden and the poor …

Neuropathic pain (NP) is pain caused by somatosensory nervous system injury or disease.
Its prominent symptoms are spontaneous pain, hyperalgesia, and allodynia, and the sense …

Neuropathic pain is a type of chronic pain caused by injury or dysfunction of the nervous
system, without effective therapeutic approaches. Mesenchymal stromal cells (MSCs) …

Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by
progressive loss of photoreceptors and eventually leads to retina degeneration and atrophy …

This study investigated the hypothesis that probiotics enhanced the therapeutic effect of
adipose-derived mesenchymal stem cells (ADMSCs) on alleviating neuropathic pain (NP) …

Purpose Neuropathic pain causes great distress among patients; however, its response to
traditional analgesia techniques remains sub-optimal. There has been progress in stem cell …

Background: Neuropathic pain is one of the more severe types of chronic pain and presents
a great challenge as response to medical therapy remains often unpredictable. With the …

Neuropathic pain (NP) is a clinically incurable disease with miscellaneous causes,
complicated mechanisms and available therapies show poor curative effect. Some recent …

Background Neuropathic pain is a complex condition that can be refractory to conventional
management and can cause persistent suffering in patients. Current pharmacologic …

Background Cell-based therapy may hold promise for treatment of chronic pain.
Mesenchymal stem cells (MSCs) are readily available and robust, and their secretion of …